Physician profile
Amjad Ali
NPI 1174523807
$1,214.87
in general payments reported to CMS, 2019-2025
9 companies · $61.79 in 2025
The $61.79 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $766 · 2020: $23.88 · 2021: $90.58 · 2023: $96.00 · 2024: $176 · 2025: $61.79.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $334.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $334.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Covidien LP | $462.91 | 2019 | |
| W. L. Gore & Associates, INC. | $288.11 | 2019 | |
| Intuitive Surgical, INC. | $171.21 | 2021-2023 | Da Vinci Surgical System |
| Ethicon US, LLC | $150.05 | 2024-2025 | Linx Reflux Management System, Evarrest, Ethicon |
| Novo Nordisk INC | $52.52 | 2023-2025 | Wegovy |
| Currax Pharmaceuticals LLC | $29.75 | 2024-2025 | Contrave, Onzetra Xsail |
| Kvk-Tech, INC. | $23.88 | 2020 | |
| Fisher Scientific Company L.L.C. | $21.28 | 2024 | Procalcitonin |
| Astellas Pharma US INC | $15.16 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amjad Ali listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.